Syndax Pharmaceuticals, Inc

(NASDAQ:SNDX)

Latest On Syndax Pharmaceuticals, Inc (SNDX):

Date/Time Type Description Signal Details
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.59 beats by $0.01N/A
2023-05-09 04:24 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 02:38 ESTNewsSyndax Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-03-04 02:40 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:35 ESTNewsSyndax Pharmaceuticals: 2023 Is A Pivotal YearN/A
2023-03-01 01:25 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04N/A
2023-02-27 19:50 ESTNewsSyndax Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-01-12 14:22 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at the 41st Annual J.P. Morgan Healthcare Conference -- SlideshowN/A
2022-12-17 03:56 ESTNewsSyndax Pharmaceuticals (SNDX) Presents at 64th ASH Annual Meeting & ExpositionN/A
2022-12-12 19:48 ESTNewsKura Oncology falls, Syndax gains after Phase 1/2 data for leukemia candidatesN/A
2022-12-10 16:27 ESTNewsSyndax Pharmaceuticals: Today's Best Nearby Biotech Cap-Gain ProspectN/A
2022-12-07 20:58 ESTNewsSyndax Pharmaceuticals prices $150M offeringN/A
2022-12-07 01:27 ESTNewsSyndax Pharma to sell $150M stock in public offeringN/A
2022-12-05 14:27 ESTNewsSyndax receives breakthrough therapy tag for revumenib to treat acute leukemiaN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) Q3 2022 Earnings Call TranscriptN/A
2022-11-06 14:31 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q3 - Results - Earnings Call PresentationN/A
2022-11-04 08:33 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.58 beats by $0.07; updates FY22 guidanceN/A
2022-11-02 23:19 ESTNewsSyndax Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q2 - Results - Earnings Call PresentationN/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.62N/A
2022-08-09 08:07 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-08 07:37 ESTNewsSyndax Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-13 12:56 ESTNewsKeith Goldan joins Syndax Pharmaceuticals as CFON/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. 2022 Q1 - Results - Earnings Call PresentationN/A
2022-05-10 14:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-09 16:51 ESTNewsSyndax Pharmaceuticals GAAP EPS of -$0.63N/A
2022-05-09 00:26 ESTNewsSyndax Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-04-08 05:11 ESTNewsSyndax Pharmaceuticals: Cash-Rich With 2 Promising DrugsN/A
2022-03-25 00:25 ESTNewsSyndax Pharmaceuticals (SNDX) Presents At Barclays Global Healthcare ConferenceN/A
2022-03-02 06:49 ESTNewsSyndax appoints former Alnylam executive as new medical chiefN/A
2022-03-02 06:49 ESTNewsSyndax Pharmaceuticals GAAP EPS of $1.81 beats by $1.84, revenue of $126.6M beats by $67.92MN/A
2022-03-02 06:48 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 18:56 ESTNewsSyndax Pharmaceuticals Q4 Earnings PreviewN/A
2022-01-29 06:36 ESTNewsSyndax Pharmaceuticals (SNDX) Investor Presentation - SlideshowN/A
2021-12-23 00:22 ESTNewsSyndax's SNDX-5613 an Orphan Drug in Europe for acute myeloid leukemiaN/A
2021-12-16 14:02 ESTNewsSyndax Pharma raises $75M via stock offeringN/A
2021-12-15 18:28 ESTNewsSyndax Pharmaceuticals drops 6% following underwritten stock offeringN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals EPS misses by $0.35, misses on revenueN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-16 08:01 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q3 - Results - Earnings Call PresentationN/A
2021-11-14 18:13 ESTNewsSyndax Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-04 16:35 ESTNewsSyndax Pharma falls after updating early-stage data for leukemia therapyN/A
2021-10-05 15:59 ESTNewsSyndax Pharma CFO Daphne Karydas to resign to pursue another opportunityN/A
2021-09-28 02:06 ESTNewsIncyte and Syndax in pact for xatilimab targeting immune-related conditionsN/A
2021-08-10 12:01 ESTNewsSyndax Pharmaceuticals EPS beats by $0.28, beats on revenueN/A
2021-08-10 12:00 ESTNewsSyndax Pharmaceuticals, Inc. (SNDX) CEO Briggs Morrison on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 11:59 ESTNewsSyndax Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call PresentationN/A
2021-07-22 02:04 ESTNewsSyndax Pharmaceuticals: Updated Analysis After Reporting Interim Phase 1 DataN/A
2021-07-22 02:02 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 01:35 ESTNewsSyndax shares rise on FDA Fast Track status for leukemia treatment SNDX-5613N/A

About Syndax Pharmaceuticals, Inc (SNDX):

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML); and SNDX-6352 or axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1, or CSF-1 receptor for the treatment of patients with chronic graft versus host disease (cGVHD). The company is also developing Entinostat. It also has collaborative research and development agreement with National Cancer Institute; a clinical trial agreement with Eastern Cooperative Oncology Group; and a license agreement with Kyowa Hakko Kirin Co., Ltd. The company was incorporated in 2005 and is headquartered in Waltham, Massachusetts.

See Advanced Chart

General

  • Name Syndax Pharmaceuticals, Inc
  • Symbol SNDX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-03-03
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.syndax.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 634.74
  • Price/Book (Most Recent Quarter) 4.43
  • Enterprise Value Revenue 542.55
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.19
  • Next Year EPS Estimate -$2.17
  • Next Quarter EPS Estimate -$0.47
  • Operating Margin -4708%
  • Return on Assets -25%
  • Return on Equity -52%
  • Revenue 1.52 million
  • Earnings Per Share -$2.36
  • Revenue Per Share $0.04
  • Gross Profit 1.52 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 1.16 billion
  • EBITDA -67280000
  • PE Ratio -125.39
  • Analyst Target Price $32.14
  • Book Value Per Share $5.27
View More

Share Statistics

  • Shares Outstanding 48.24 million
  • Shares Float 42.95 million
  • % Held by Insiders 645%
  • % Held by Institutions 78.88%
  • Shares Short 4.93 million
  • Shares Short Prior Month 4.93 million
  • Short Ratio 9.27
  • Short % of Float 11%
  • Short % of Shares Outstanding 10%
View More

Technicals

  • Beta 1.84
  • 52 Week High $27.12
  • 52 Week Low $8.18
  • 50 Day Moving Average 22.33
  • 200 Day Moving Average 20.55
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Syndax Pharmaceuticals, Inc (SNDX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Syndax Pharmaceuticals, Inc (SNDX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-08$380000-$0.44-$0.5113.23%
2020-09-302020-11-02$N/A-$0.46-$0.43-6.75%
2020-06-302020-08-06$N/A-$0.42-$0.444.76%
2020-03-312020-05-07$379000-$0.56-$0.53-6.65%
2019-12-312020-03-03$380000-$0.44-$0.43-1.31%
2019-09-302019-11-07$379000-$0.41-$0.4813.92%
2019-06-302019-08-07$379000-$0.47-$0.470.76%
2019-03-312019-05-06$379000-$0.53-$0.554.14%
2018-12-312019-03-07$379000-$0.70-$0.64-9.43%
2018-09-302018-11-05$379000-$0.68-$0.7610.21%
2018-06-302018-08-07$379000-$0.74-$0.8916.94%
2018-03-312018-05-08$379000-$0.79-$0.9517.15%
2017-12-312018-03-05$1.19 million-$0.80-$0.77-3.67%
2017-09-302017-11-07$305000-$0.68-$0.8216.63%
2017-06-302017-08-10$305000-$0.70-$0.8214.83%
2017-03-312017-05-08$305000-$0.71-$0.710.56%
2016-12-312017-03-02$305000-$0.59-$0.7419.79%
2016-09-302016-11-10$305000-$0.84-$0.82-2.78%
2016-06-302016-08-09$305000-$0.47-$0.5412.18%
2016-03-312016-05-16$305000-$0.73-$0.48-52.22%

Syndax Pharmaceuticals, Inc (SNDX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Syndax Pharmaceuticals, Inc (SNDX) Chart:

Syndax Pharmaceuticals, Inc (SNDX) News:

Below you will find a list of latest news for Syndax Pharmaceuticals, Inc (SNDX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Syndax Pharmaceuticals, Inc (SNDX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-08-21100CALL0 078.13TRUE00
2026-08-21110CALL0 096.92TRUE00
2026-08-21120CALL0 080.16TRUE00
2026-08-21130CALL0 0110.82TRUE00
2026-08-21140CALL0 292.85TRUE00
2026-08-21150CALL0 1789.67TRUE00
2026-08-21160CALL0 181.5TRUE00
2026-08-21170CALL0 081.21TRUE00
2026-08-21180CALL0 177.53TRUE00
2026-08-21190CALL0 662.35TRUE00
2026-08-21200CALL0 16768.87FALSE00
2026-08-21210.55CALL1 781.39FALSE0.550
2026-08-21220CALL0 12475.07FALSE00
2026-08-21230CALL0 5377.59FALSE00
2026-08-21240CALL0 143128.77FALSE00
2026-08-21250CALL0 463118.31FALSE00
2026-08-21260CALL0 31161.89FALSE00
2026-08-21270CALL0 46177.46FALSE00
2026-08-21280CALL0 24192.47FALSE00
2026-08-21290CALL0 5201.81FALSE00
2026-08-21300CALL0 104208.87FALSE00
2026-08-21310CALL0 0217.22FALSE00
2026-08-21320CALL0 1225.16FALSE00
2026-08-21330CALL0 0230.87FALSE00
2026-08-21340CALL0 0238.08FALSE00
2026-08-21350CALL0 10244.98FALSE00
2026-08-21360CALL0 0251.6FALSE00
2026-08-21370CALL0 0257.95FALSE00
2026-08-21380CALL0 0264.07FALSE00
2026-08-21390CALL0 0269.96FALSE00
2026-08-21400CALL0 0191.45FALSE00
2026-08-21100PUT0 0129.85FALSE00
2026-08-21110PUT0 0285.35FALSE00
2026-08-21120PUT0 0252.58FALSE00
2026-08-21130PUT0 0224.62FALSE00
2026-08-21140PUT0 2198.21FALSE00
2026-08-21150PUT0 1076.55FALSE00
2026-08-21160.35PUT5 877.26FALSE0.350
2026-08-21170PUT0 8170.69FALSE00
2026-08-21180PUT0 4961.04FALSE00
2026-08-21191.46PUT5 2244.57FALSE0.160.12
2026-08-21201.8PUT0 60365.17TRUE00
2026-08-21210PUT0 1258TRUE00
2026-08-21220PUT0 364.28TRUE00
2026-08-21230PUT0 1076.3TRUE00
2026-08-21240PUT0 582.26TRUE00
2026-08-21250PUT0 56102.27TRUE00
2026-08-21260PUT0 0106.79TRUE00
2026-08-21270PUT0 0115.63TRUE00
2026-08-21280PUT0 0117.97TRUE00
2026-08-21290PUT0 0125.66TRUE00
2026-08-21300PUT0 0132.97TRUE00
2026-08-21310PUT0 0132.58TRUE00
2026-08-21320PUT0 1146.58TRUE00
2026-08-21330PUT0 0152.96TRUE00
2026-08-21340PUT0 0178.25TRUE00
2026-08-21350PUT0 0172.02TRUE00
2026-08-21360PUT0 1177.81TRUE00
2026-08-21370PUT0 0196.19TRUE00
2026-08-21380PUT0 0172.89TRUE00
2026-08-21390PUT0 0177.87TRUE00
2026-08-21400PUT0 0191.34TRUE00
2026-09-18110CALL0 061.18TRUE00
2026-09-18120CALL0 078.78TRUE00
2026-09-18130CALL0 079.48TRUE00
2026-09-18140CALL0 075.71TRUE00
2026-09-18150CALL0 071.29TRUE00
2026-09-18160CALL0 068.73TRUE00
2026-09-18170CALL0 467.76TRUE00
2026-09-18180CALL0 047.81TRUE00
2026-09-18190CALL0 164.9TRUE00
2026-09-18201.4CALL6 3158.37FALSE1.40
2026-09-18210CALL0 167.19FALSE00
2026-09-18220CALL0 40061.02FALSE00
2026-09-18230CALL0 861.01FALSE00
2026-09-18240CALL0 090.03FALSE00
2026-09-18250CALL0 7994.6FALSE00
2026-09-18260CALL0 30394.9FALSE00
2026-09-18270CALL0 2121.61FALSE00
2026-09-18280CALL0 2125.93FALSE00
2026-09-18290CALL0 2130.89FALSE00
2026-09-18300CALL0 12128.53FALSE00
2026-09-18310CALL0 1139.74FALSE00
2026-09-18320CALL0 3144.87FALSE00
2026-09-18330CALL0 0148.57FALSE00
2026-09-18340CALL0 0153.23FALSE00
2026-09-18350CALL0 3157.69FALSE00
2026-09-18360CALL0 0127.95FALSE00
2026-09-18370CALL0 0166.08FALSE00
2026-09-18380CALL0 0170.03FALSE00
2026-09-18390CALL0 0173.84FALSE00
2026-09-18400CALL0 0177.51FALSE00
2026-09-18110PUT0 0184.83FALSE00
2026-09-18120PUT0 0165.3FALSE00
2026-09-18130PUT0 0147.12FALSE00
2026-09-18140PUT0 0132.67FALSE00
2026-09-18150PUT0 0117.27FALSE00
2026-09-18160PUT0 085.99FALSE00
2026-09-18170PUT0 056.86FALSE00
2026-09-18180PUT0 2349.16FALSE00
2026-09-18190PUT0 674.48FALSE00
2026-09-18200PUT0 272.49TRUE00
2026-09-18210PUT0 038.96TRUE00
2026-09-18220PUT0 30569.77TRUE00
2026-09-18230PUT0 181.25TRUE00
2026-09-18240PUT0 066.99TRUE00
2026-09-18250PUT0 268.51TRUE00
2026-09-18260PUT0 068.35TRUE00
2026-09-18270PUT0 270.18TRUE00
2026-09-18280PUT0 064.9TRUE00
2026-09-18290PUT0 069.54TRUE00
2026-09-18300PUT0 089.64TRUE00
2026-09-18310PUT0 189.86TRUE00
2026-09-18320PUT0 0110.13TRUE00
2026-09-183314.1PUT2 0121.26TRUE14.10
2026-09-18340PUT0 0111.47TRUE00
2026-09-18350PUT0 0106.35TRUE00
2026-09-18360PUT0 082.19TRUE00
2026-09-18370PUT0 085.32TRUE00
2026-09-18380PUT0 0103.75TRUE00
2026-09-18390PUT0 0106.94TRUE00
2026-09-18400PUT0 0110.04TRUE00
2026-10-16100CALL0 195.38TRUE00
2026-10-16110CALL0 092.82TRUE00
2026-10-16120CALL0 088.14TRUE00
2026-10-16130CALL0 282.25TRUE00
2026-10-16140CALL0 080.64TRUE00
2026-10-16150CALL0 2076.99TRUE00
2026-10-16160CALL0 077.45TRUE00
2026-10-16170CALL0 080.58TRUE00
2026-10-16180CALL0 875.91TRUE00
2026-10-16190CALL0 157.42TRUE00
2026-10-16200CALL0 358.04FALSE00
2026-10-16210CALL0 058.76FALSE00
2026-10-16220CALL0 1360.67FALSE00
2026-10-16230CALL0 067.5FALSE00
2026-10-16240CALL0 064.32FALSE00
2026-10-16250CALL0 19068.55FALSE00
2026-10-16260CALL0 170.25FALSE00
2026-10-16270CALL0 973.26FALSE00
2026-10-16280CALL0 2107.29FALSE00
2026-10-16290CALL0 0110.54FALSE00
2026-10-16300CALL0 50114.33FALSE00
2026-10-16310CALL0 0117.85FALSE00
2026-10-16320CALL0 0120.24FALSE00
2026-10-16330CALL0 0123.29FALSE00
2026-10-16340CALL0 0127.05FALSE00
2026-10-16350CALL0 0129.73FALSE00
2026-10-16360CALL0 0132.23FALSE00
2026-10-16370CALL0 0135.53FALSE00
2026-10-16380CALL0 0117.49FALSE00
2026-10-16390CALL0 0140.79FALSE00
2026-10-16400CALL0 0127.86FALSE00
2026-10-16100PUT0 0170.46FALSE00
2026-10-16110PUT0 1153FALSE00
2026-10-16120PUT0 126138.25FALSE00
2026-10-16130PUT0 0125.57FALSE00
2026-10-16140PUT0 0113.38FALSE00
2026-10-16150PUT0 568.82FALSE00
2026-10-16160PUT0 064.08FALSE00
2026-10-16170PUT0 13167.29FALSE00
2026-10-16180PUT0 1554.49FALSE00
2026-10-16190PUT0 076.78FALSE00
2026-10-16200PUT0 1155.54TRUE00
2026-10-16210PUT0 1557.02TRUE00
2026-10-16220PUT0 157.34TRUE00
2026-10-16230PUT0 3172.14TRUE00
2026-10-16240PUT0 171.07TRUE00
2026-10-16250PUT0 1575.69TRUE00
2026-10-16260PUT0 072.19TRUE00
2026-10-16270PUT0 073.24TRUE00
2026-10-16280PUT0 075.81TRUE00
2026-10-16290PUT0 077.93TRUE00
2026-10-16300PUT0 076.76TRUE00
2026-10-16310PUT0 095.66TRUE00
2026-10-16320PUT0 095.06TRUE00
2026-10-16330PUT0 090.96TRUE00
2026-10-16340PUT0 075.18TRUE00
2026-10-16350PUT0 0100.69TRUE00
2026-10-16360PUT0 081.13TRUE00
2026-10-16370PUT0 0101.06TRUE00
2026-10-16380PUT0 0100.58TRUE00
2026-10-16390PUT0 0106.92TRUE00
2026-10-16400PUT0 0106.18TRUE00
2026-11-20100CALL0 093.49TRUE00
2026-11-20110CALL0 091.2TRUE00
2026-11-20120CALL0 087.32TRUE00
2026-11-20130CALL0 0102.75TRUE00
2026-11-20140CALL0 084.4TRUE00
2026-11-20150CALL0 084.08TRUE00
2026-11-20160CALL0 083.71TRUE00
2026-11-20170CALL0 081.3TRUE00
2026-11-20180CALL0 071.47TRUE00
2026-11-20190CALL0 063.1TRUE00
2026-11-20200CALL0 072.99FALSE00
2026-11-20210CALL0 061.23FALSE00
2026-11-20220CALL0 176.53FALSE00
2026-11-20230CALL0 062.37FALSE00
2026-11-20240CALL0 080.85FALSE00
2026-11-20251.4CALL40 182.02FALSE1.40
2026-11-20260CALL0 078.63FALSE00
2026-11-20270CALL0 069.01FALSE00
2026-11-20280CALL0 10382.02FALSE00
2026-11-20290CALL0 172.93FALSE00
2026-11-20300CALL0 6473.91FALSE00
2026-11-20310CALL0 0100.65FALSE00
2026-11-20320CALL0 0103.43FALSE00
2026-11-20330CALL0 6105.3FALSE00
2026-11-20350CALL0 0109.98FALSE00
2026-11-20100PUT0 0145.42FALSE00
2026-11-20110PUT0 0132.89FALSE00
2026-11-20120PUT0 0108.62FALSE00
2026-11-20130PUT0 0111.11FALSE00
2026-11-20140PUT0 075.37FALSE00
2026-11-20150PUT0 078.99FALSE00
2026-11-20160PUT0 066.77FALSE00
2026-11-20170PUT0 063.93FALSE00
2026-11-20180PUT0 064.33FALSE00
2026-11-20190PUT0 165.61FALSE00
2026-11-20200PUT0 064.83TRUE00
2026-11-20210PUT0 063.37TRUE00
2026-11-20220PUT0 065.55TRUE00
2026-11-20230PUT0 063.57TRUE00
2026-11-20240PUT0 073.48TRUE00
2026-11-20250PUT0 073.86TRUE00
2026-11-20260PUT0 073.49TRUE00
2026-11-20270PUT0 072.29TRUE00
2026-11-20280PUT0 078.16TRUE00
2026-11-20290PUT0 077.5TRUE00
2026-11-20300PUT0 074.27TRUE00
2026-11-20310PUT0 075.82TRUE00
2026-11-20320PUT0 074.91TRUE00
2026-11-20330PUT0 073.11TRUE00
2026-11-20350PUT0 075.92TRUE00
2027-01-1530CALL0 0106.31TRUE00
2027-01-1550CALL0 0114.13TRUE00
2027-01-1580CALL0 13104TRUE00
2027-01-1590CALL0 097.15TRUE00
2027-01-15100CALL0 3895.33TRUE00
2027-01-15110CALL0 092.18TRUE00
2027-01-15120CALL0 1091.78TRUE00
2027-01-15130CALL0 7890.02TRUE00
2027-01-15140CALL0 088.73TRUE00
2027-01-15150CALL0 16586.53TRUE00
2027-01-15160CALL0 185.97TRUE00
2027-01-15170CALL0 784.55TRUE00
2027-01-15180CALL0 086.67TRUE00
2027-01-15190CALL0 473.07TRUE00
2027-01-15200CALL0 11980.84FALSE00
2027-01-15210CALL0 2274.92FALSE00
2027-01-15220CALL0 755974.78FALSE00
2027-01-15230CALL0 467.68FALSE00
2027-01-15240CALL0 2077.17FALSE00
2027-01-15250CALL0 6567.77FALSE00
2027-01-15260CALL0 1868.31FALSE00
2027-01-15270CALL0 9574.84FALSE00
2027-01-15280CALL0 10080.61FALSE00
2027-01-15290CALL0 883.53FALSE00
2027-01-15300CALL0 12079.65FALSE00
2027-01-15310CALL0 2989.34FALSE00
2027-01-15320CALL0 1274.03FALSE00
2027-01-15330CALL0 3174.66FALSE00
2027-01-15340CALL0 1075.76FALSE00
2027-01-15350CALL0 2676.69FALSE00
2027-01-15360CALL0 1178.19FALSE00
2027-01-15370CALL0 599.25FALSE00
2027-01-15380.85CALL0 480.87FALSE00
2027-01-15390CALL0 25104.19FALSE00
2027-01-15400CALL0 259105.05FALSE00
2027-01-1511050CALL0 00FALSE00
2027-01-1511100CALL0 00FALSE00
2027-01-1511150CALL0 00FALSE00
2027-01-1511200CALL0 00FALSE00
2027-01-1511250CALL0 00FALSE00
2027-01-1511300CALL0 00FALSE00
2027-01-1511350CALL0 00FALSE00
2027-01-1511400CALL0 00FALSE00
2027-01-1511450CALL0 00FALSE00
2027-01-1511500CALL0 00FALSE00
2027-01-1511550CALL0 00FALSE00
2027-01-1511600CALL0 00FALSE00
2027-01-1511650CALL0 00FALSE00
2027-01-1511700CALL0 00FALSE00
2027-01-1511750CALL0 00FALSE00
2027-01-1511800CALL0 00FALSE00
2027-01-1511850CALL0 00FALSE00
2027-01-1511900CALL0 00FALSE00
2027-01-1511950CALL0 00FALSE00
2027-01-1516600CALL0 00FALSE00
2027-01-1516700CALL0 00FALSE00
2027-01-1516800CALL0 00FALSE00
2027-01-1516900CALL0 00FALSE00
2027-01-1517000CALL0 00FALSE00
2027-01-1517100CALL0 00FALSE00
2027-01-1517200CALL0 00FALSE00
2027-01-1530PUT0 0283.28FALSE00
2027-01-1550PUT0 2111.5FALSE00
2027-01-1580PUT0 4152.84FALSE00
2027-01-1590PUT0 2139.39FALSE00
2027-01-15100PUT0 3127.35FALSE00
2027-01-15110PUT0 0118.16FALSE00
2027-01-15120PUT0 0108.65FALSE00
2027-01-15130PUT0 5101.14FALSE00
2027-01-15140PUT0 281.29FALSE00
2027-01-15150PUT0 2492.15FALSE00
2027-01-15160PUT0 790.95FALSE00
2027-01-15172.85PUT0 2484.01FALSE00
2027-01-15180PUT0 474.81FALSE00
2027-01-15190PUT0 186.85FALSE00
2027-01-15200PUT0 271.66TRUE00
2027-01-15210PUT0 3274.87TRUE00
2027-01-15220PUT0 575.41TRUE00
2027-01-15236.3PUT0 982.18TRUE00
2027-01-15240PUT0 081.6TRUE00
2027-01-15250PUT0 10774.47TRUE00
2027-01-15260PUT0 079.95TRUE00
2027-01-15270PUT0 083.1TRUE00
2027-01-15280PUT0 082.81TRUE00
2027-01-15290PUT0 081TRUE00
2027-01-15300PUT0 9381.01TRUE00
2027-01-15310PUT0 083.06TRUE00
2027-01-15320PUT0 082.51TRUE00
2027-01-15330PUT0 082.87TRUE00
2027-01-15340PUT0 086.92TRUE00
2027-01-15350PUT0 088.25TRUE00
2027-01-15360PUT0 082.3TRUE00
2027-01-15370PUT0 179.82TRUE00
2027-01-15380PUT0 082.07TRUE00
2027-01-15390PUT0 082.46TRUE00
2027-01-15400PUT0 782.66TRUE00
2027-01-1511050PUT0 00TRUE00
2027-01-1511100PUT0 00TRUE00
2027-01-1511150PUT0 00TRUE00
2027-01-1511200PUT0 00TRUE00
2027-01-1511250PUT0 00TRUE00
2027-01-1511300PUT0 00TRUE00
2027-01-1511350PUT0 00TRUE00
2027-01-1511400PUT0 00TRUE00
2027-01-1511450PUT0 00TRUE00
2027-01-1511500PUT0 00TRUE00
2027-01-1511550PUT0 00TRUE00
2027-01-1511600PUT0 00TRUE00
2027-01-1511650PUT0 00TRUE00
2027-01-1511700PUT0 00TRUE00
2027-01-1511750PUT0 00TRUE00
2027-01-1511800PUT0 00TRUE00
2027-01-1511850PUT0 00TRUE00
2027-01-1511900PUT0 00TRUE00
2027-01-1511950PUT0 00TRUE00
2027-01-1516600PUT0 00TRUE00
2027-01-1516700PUT0 00TRUE00
2027-01-1516800PUT0 00TRUE00
2027-01-1516900PUT0 00TRUE00
2027-01-1517000PUT0 00TRUE00
2027-01-1517100PUT0 00TRUE00
2027-01-1517200PUT0 00TRUE00
2028-01-2130CALL0 1108.8TRUE00
2028-01-2150CALL0 070.18TRUE00
2028-01-2180CALL0 080.13TRUE00
2028-01-21100CALL0 4076.68TRUE00
2028-01-21130CALL0 375.4TRUE00
2028-01-21150CALL0 073.94TRUE00
2028-01-21170CALL0 674.63TRUE00
2028-01-21206.7CALL9 11084.1FALSE6.70
2028-01-21220CALL0 973FALSE00
2028-01-21250CALL0 11673.16FALSE00
2028-01-21274.78CALL30 8472.24FALSE4.780
2028-01-21300CALL0 11073.33FALSE00
2028-01-21320CALL0 1974.25FALSE00
2028-01-21350CALL0 2773.6FALSE00
2028-01-21373.13CALL30 8072.31FALSE3.130
2028-01-21400CALL0 4974.77FALSE00
2028-01-2116600CALL0 00FALSE00
2028-01-2116800CALL0 00FALSE00
2028-01-2117000CALL0 00FALSE00
2028-01-2117200CALL0 00FALSE00
2028-01-2130PUT0 0315.57FALSE00
2028-01-2150PUT0 0183.97FALSE00
2028-01-2180PUT0 0121.68FALSE00
2028-01-21100PUT0 397.57FALSE00
2028-01-21130PUT0 7884.15FALSE00
2028-01-21150PUT0 2771.67FALSE00
2028-01-21170PUT0 4873.7FALSE00
2028-01-21200PUT0 172.49TRUE00
2028-01-21220PUT0 274.39TRUE00
2028-01-21250PUT0 11672.79TRUE00
2028-01-21270PUT0 072.77TRUE00
2028-01-21300PUT0 074.46TRUE00
2028-01-21320PUT0 173.05TRUE00
2028-01-21350PUT0 173TRUE00
2028-01-21370PUT0 073.48TRUE00
2028-01-21400PUT0 2975.03TRUE00
2028-01-2116600PUT0 00TRUE00
2028-01-2116800PUT0 00TRUE00
2028-01-2117000PUT0 00TRUE00
2028-01-2117200PUT0 00TRUE00

Latest SNDX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST3$15.6
Jun 13, 2022 7:59 PM EST4$15.6
Jun 13, 2022 7:59 PM EST1$15.6
Jun 13, 2022 7:59 PM EST100$15.61
Jun 13, 2022 7:59 PM EST45$15.61

Syndax Pharmaceuticals, Inc (SNDX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2019-09-05UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1395937/000000000019013216/0000000000-19-013216-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000021545719006549/0000215457-19-006549-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720006818/0000834237-20-006818-index.htm
2020-09-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000083423720010194/0000834237-20-010194-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221919000254/0000902219-19-000254-index.htm
2020-01-28SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090221920000308/0000902219-20-000308-index.htm
2019-04-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266419001816/0000902664-19-001816-index.htm
2020-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000090266420000971/0000902664-20-000971-index.htm
2020-11-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000091957420006675/0000919574-20-006675-index.htm
2018-06-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518001976/0000921895-18-001976-index.htm
2018-11-29SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189518003173/0000921895-18-003173-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189519000467/0000921895-19-000467-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000092189520000574/0000921895-20-000574-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359419000160/0001013594-19-000160-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000101359420000127/0001013594-20-000127-index.htm
2018-04-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018005/0001140361-18-018005-index.htm
2018-04-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1395937/000114036118018007/0001140361-18-018007-index.htm
2018-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312518197997/0001193125-18-197997-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519034379/0001193125-19-034379-index.htm
2019-03-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519088951/0001193125-19-088951-index.htm
2019-03-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312519092679/0001193125-19-092679-index.htm
2019-03-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519092701/0001193125-19-092701-index.htm
2019-08-30S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1395937/000119312519235283/0001193125-19-235283-index.htm
2019-09-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1395937/000119312519239953/0001193125-19-239953-index.htm
2019-09-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312519242045/0001193125-19-242045-index.htm
2019-10-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312519265254/0001193125-19-265254-index.htm
2020-02-03424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000119312520022917/0001193125-20-022917-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000119312520023646/0001193125-20-023646-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520037637/0001193125-20-037637-index.htm
2020-05-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1395937/000119312520139263/0001193125-20-139263-index.htm
2018-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002680/0001562180-18-002680-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002681/0001562180-18-002681-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002682/0001562180-18-002682-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002683/0001562180-18-002683-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002684/0001562180-18-002684-index.htm
2018-05-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018002685/0001562180-18-002685-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004047/0001562180-18-004047-index.htm
2018-09-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004048/0001562180-18-004048-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004049/0001562180-18-004049-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004050/0001562180-18-004050-index.htm
2018-11-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000852/0001562180-19-000852-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000853/0001562180-19-000853-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000854/0001562180-19-000854-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000855/0001562180-19-000855-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019000856/0001562180-19-000856-index.htm
2019-03-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-254/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002023/0001562180-19-002023-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003487/0001562180-19-003487-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003488/0001562180-19-003488-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003489/0001562180-19-003489-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003490/0001562180-19-003490-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003491/0001562180-19-003491-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003492/0001562180-19-003492-index.htm
2019-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019003880/0001562180-19-003880-index.htm
2019-10-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001228/0001562180-20-001228-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001229/0001562180-20-001229-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001230/0001562180-20-001230-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001231/0001562180-20-001231-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001232/0001562180-20-001232-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001233/0001562180-20-001233-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001234/0001562180-20-001234-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001235/0001562180-20-001235-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001236/0001562180-20-001236-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001237/0001562180-20-001237-index.htm
2020-02-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-07-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-07-133Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020005102/0001562180-20-005102-index.htm
2020-11-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2018-03-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018004520/0001564590-18-004520-index.htm
2018-03-0810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459018004911/0001564590-18-004911-index.htm
2018-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018011784/0001564590-18-011784-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018012378/0001564590-18-012378-index.htm
2018-05-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018014349/0001564590-18-014349-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018019907/0001564590-18-019907-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018020483/0001564590-18-020483-index.htm
2018-08-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459018020504/0001564590-18-020504-index.htm
2018-09-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018023593/0001564590-18-023593-index.htm
2018-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459018026817/0001564590-18-026817-index.htm
2018-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459018026892/0001564590-18-026892-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019002676/0001564590-19-002676-index.htm
2019-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019006772/0001564590-19-006772-index.htm
2019-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019006777/0001564590-19-006777-index.htm
2019-03-1810-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459019008313/0001564590-19-008313-index.htm
2019-04-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019014263/0001564590-19-014263-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019015972/0001564590-19-015972-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019017318/0001564590-19-017318-index.htm
2019-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019022241/0001564590-19-022241-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019024625/0001564590-19-024625-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030050/0001564590-19-030050-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019030067/0001564590-19-030067-index.htm
2019-08-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459019030084/0001564590-19-030084-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019036518/0001564590-19-036518-index.htm
2019-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019041712/0001564590-19-041712-index.htm
2019-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459019041719/0001564590-19-041719-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459019045581/0001564590-19-045581-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020004037/0001564590-20-004037-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020005551/0001564590-20-005551-index.htm
2020-03-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020008426/0001564590-20-008426-index.htm
2020-03-0510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1395937/000156459020009016/0001564590-20-009016-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019694/0001564590-20-019694-index.htm
2020-04-30424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020019928/0001564590-20-019928-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020019941/0001564590-20-019941-index.htm
2020-05-04424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020020574/0001564590-20-020574-index.htm
2020-05-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020020633/0001564590-20-020633-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020022849/0001564590-20-022849-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020022971/0001564590-20-022971-index.htm
2020-06-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020028764/0001564590-20-028764-index.htm
2020-07-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020031882/0001564590-20-031882-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037719/0001564590-20-037719-index.htm
2020-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1395937/000156459020037767/0001564590-20-037767-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020037777/0001564590-20-037777-index.htm
2020-11-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1395937/000156459020049638/0001564590-20-049638-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1395937/000156459020051287/0001564590-20-051287-index.htm
2019-09-10EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1395937/999999999519002056/9999999995-19-002056-index.htm
2018-11-27CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999716026189/9999999997-16-026189-index.htm
2018-04-03CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718004150/9999999997-18-004150-index.htm
2018-06-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718006372/9999999997-18-006372-index.htm
2018-08-29CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718007508/9999999997-18-007508-index.htm
2018-12-20CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999718009113/9999999997-18-009113-index.htm
2019-03-28CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1395937/999999999719002097/9999999997-19-002097-index.htm

Syndax Pharmaceuticals, Inc (SNDX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Syndax Pharmaceuticals, Inc (SNDX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 645%
Institutional Ownership: 7888%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-04-03Peter OrdentlichChief Scientific OfficerSell7,500.0015.00112,500.000.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm
2020-07-06Michael L. MeyersSVP, Chief Medical OfficerBuy3,500.0010,730.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020005074/0001562180-20-005074-index.htm
2020-11-04Michael A MetzgerPresident and COOBuy100,000.007.20720,000.00117,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-09Briggs MorrisonChief Executive OfficerBuy13,200.007.5699,726.0013,200.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2020-02-12Michael A MetzgerPresident and COOBuy15,000.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020001238/0001562180-20-001238-index.htm
2020-11-04Michael A MetzgerPresident and COOSell100,000.0020.312,031,410.0017,659.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020006583/0001562180-20-006583-index.htm
2019-05-13Briggs MorrisonChief Executive OfficerBuy7,200.007.2952,516.8020,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002780/0001562180-19-002780-index.htm
2018-10-30Michael L. MeyersSVP, Chief Medical OfficerBuy200.004.79958.002,398.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018004443/0001562180-18-004443-index.htm
2019-10-10Briggs MorrisonChief Executive OfficerBuy11,000.005.4059,400.0031,400.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019005140/0001562180-19-005140-index.htm
2020-02-04Briggs MorrisonChief Executive OfficerBuy12,500.008.00100,000.0043,900.00https://www.sec.gov/Archives/edgar/data/1395937/000156218020000891/0001562180-20-000891-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy1,000.004.934,930.007,118.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2019-03-21Michael L. MeyersSVP, Chief Medical OfficerBuy104.004.87506.487,222.00https://www.sec.gov/Archives/edgar/data/1395937/000156218019002012/0001562180-19-002012-index.htm
2018-04-03Peter OrdentlichChief Scientific OfficerBuy7,500.003.0823,100.007,500.00https://www.sec.gov/Archives/edgar/data/1395937/000156218018001800/0001562180-18-001800-index.htm